New Japanese guidelines would allow for gene editing of human embryos for research purposes, according to Nature News.
Japan's science ministry wants a budget increase of about 20 percent, Science reports.
Japanese broadcaster NHK reports that a Japanese government panel has decided not to regulate some types of gene editing.
The firm's ROS1 gene fusion kit was approved as a companion diagnostic for Pfizer's Xalkori.
The Japan Times says regulations are needed to oversee human genome-editing research.
Japan needs to catch up on its gene-editing research efforts, the Japan News writes.
Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.
The center, based in Yokohama, Japan, will likely purchase at least one single-molecule sequencer in order to avoid PCR-induced bias in Cap Analysis of Gene Expression, a method its researchers developed.
A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.
A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.
In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.
A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.